Skip to content

TRISPOLIS

Active
Private limited company·Activiteiten van medisch specialisten· 4 yrs active
de Rivierendreef 210 ·1090 Jette, Belgium
BE 0780.580.279
Watch Print / PDF
Age4 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of TRISPOLIS is 0.4% (very low). The 2024 annual accounts show equity of €375k and a net result of €177k. Equity is growing by ~73.9% per year across the filed fiscal years. Its solvency ranks better than 73% of 6549 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Trust signals

3 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.4% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€177k+53.6%
Working capital€342k+99.3%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 25-07-2025 with the NBB · fiscal year 2024 · micro
€0€100k€200kOperating result 2022: €117k€117kNet result 2022: €82k€82kOperating result 2023: €151k€151kNet result 2023: €115k€115kOperating result 2024: €232k€232kNet result 2024: €177k€177k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~73.9%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€200k€400k€600k€800k2025: €521k (€491k - €551k)2026: €668k (€638k - €698k)2027: €814k (€784k - €844k)2022: €83k2023: €198k2024: €375k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 81.7% 66.7%
better than 73% of 6549 sector peers
Net result €177k €46k
better than 92% of 6543 sector peers
Equity €375k €79k
better than 92% of 6549 sector peers
Gross operating margin €249k €78k
better than 90% of 6551 sector peers
Total assets €459k €154k
better than 86% of 6552 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€249k
+47.9% far above sector median
Net profit
€177k
+53.6% far above sector median
Cash flow
€194k
+46.8% far above sector median
Total assets
€459k
+60.8% -23% vs sector
Equity
€375k
+89.5% ≈ vs sector
Working capital
€342k
+99.3% +111% vs sector
Income taxes
€55k
+54.4% far above sector median
Debt
€84k
-4.0% -63% vs sector
Debt ≤ 1y
€82k
+30.5% -24% vs sector
Debt > 1y
€2k
-92.3% -97% vs sector
Current ratio
5.16
+38.6% +26% vs sector
Quick ratio
5.16
+38.6% +26% vs sector
Solvency
81.7%
+17.8% +31% vs sector
Debt / equity
0.22
-49.3% -63% vs sector
ROE
47.2%
-18.9% far above sector median
ROA
38.6%
-4.5% far above sector median
Interest coverage
472.50
+113.3% far above sector median
Figures by fiscal year
Fiscal year2024
Revenue-
EBITDA€249k
Net profit€177k
Cash flow€194k
Staff costs-
Income taxes€55k
Dividends-
Total assets€459k
Equity€375k
Debt€84k
of which ≤ 1y€82k
of which > 1y€2k
Working capital€342k
Employees (FTE)-
Ratios (computed)
2024
Current ratio5.16
Quick ratio5.16
Working capital ratio74.5%
Solvency81.7%
Debt / equity0.22
Long-term debt ratio0.01
Interest coverage472.50
Gross margin-
Net margin-
ROA38.6%
ROE47.2%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€459k
Fixed assets 21/28€35k
Tangible fixed assets 22/27€35k
Financial fixed assets 28€125
Current assets 29/58€424k
Amounts receivable within one year 40/41€60k
Cash & bank 54/58€357k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€459k
Equity 10/15€375k
Contributions / capital 10/11€500
Reserves 13€82k
Accumulated profits (losses) 14€292k
Amounts payable 17/49€84k
Amounts payable after one year 17€2k
Amounts payable within one year 42/48€82k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€249k
Operating result 9901€232k
Financial income 75€236
Financial charges 65€527
Result before taxes 9903€232k
Income taxes 67/77€55k
Net result for the period 9904€177k
Result to be appropriated 9905€177k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
100 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

2 locations
Romeinsesteenweg 801, 1020 Brussel
Activiteiten van medisch specialisten
since 20222.327.461.748
Jules Graindorlaan 66, 1070 Anderlecht
Activiteiten van medisch specialisten
since 20222.327.461.847
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels3
Ground area1.9 ha
Buildings3
Building footprint4,739 m²
Volume (LiDAR)91,182 m³
Tallest building36.1 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 3 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21304B0056/00W000 Brussels 1.7 ha 1 · 4,271 m² 36.0 m · 5 fl.
21463C0430/00N002 Brussels 963 m² 1 · 294 m² 19.4 m · 5 fl.
21816G0043/00T002 Brussels 952 m² 1 · 173 m² 12.2 m · 3 fl.
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency100Growth78Stability94
94 / 100

Exceptional profile, strong across almost every axis.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameFR TRISPOLIS
Registered office
de Rivierendreef 210 bus 10
1090 Jette, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.